# Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment

> **NCT05435352** · — · TERMINATED · sponsor: **Ourotech, Inc.** · enrollment: 34 (actual)

## Conditions studied

- Triple Negative Breast Cancer
- Triple Negative Breast Neoplasms

## Interventions

- **PROCEDURE:** Core needle biopsy

## Key facts

- **NCT ID:** NCT05435352
- **Lead sponsor:** Ourotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-06
- **Primary completion:** 2025-07-25
- **Final completion:** 2025-07-25
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05435352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05435352, "Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05435352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*